EPICUP® Epigenetic Test Helps Clinical Management of Primary Tumor

When the origin of the cancer is not identified with confidence, after initial tests, this is described as Cancer of Unknown Primary or CUP.

Cancer of unknown primary means that cancer spread has been found in your body, but your doctors can't find where the cancer started. It is sometimes called unknown primary cancer or unknown primary tumor.

Finding the genetic origin of the cancer is important to define the best treatment. The invention of the EPICUP® epigenetic test last year allowed physicians to elucidate what type of primary tumor had metastasized in patients with Cancer of Unknown Primary (CUP).

Chemotherapy More Effective In Those With Right-sided Colorectal Tumors
Patients with right-sided primary tumor treated with chemotherapy plus selective internal radiation therapy have a 36% reduced risk of dying at any time point.

‘A cancer diagnosis is frightening for patient, family and friends. Not to know where this strange, invasive, disease has originated in the body is a double blow.’

An article published in Nature Reviews Clinical Oncology by Dr. Manel Esteller, coordinator of the Epigenetics and Cancer Biology Program of the Bellvitge Biomedical Research Institute (IDIBELL), ICREA Researcher and Professor of Genetics at the University of Barcelona, explains how this test is being transferred to the clinical practice and the new advances that can develop from it.

" Traditional methods can only detect the primary tumor in 30% of cases of metastases of unknown origin. Some molecular methods could increase this percentage, but they are often expensive and use the RNA molecule (ribonucleic acid), which is very fragile and is often easily broken down in the samples available in the pathological anatomy services of hospitals", Dr. Manel Esteller explains.

"The EPICUP® test, on the other hand, is based on the DNA molecule, which is very stable, so it can be sent from the hospital where the patient is to the analysis laboratory in a simpler way. The results can be obtained in a week " adds the researcher.

Microscope can Scan Tumors During Surgery
All cancers begin in cells. Our bodies are made up of more than a hundred million cells. Cancer starts with changes in one cell or a small group of cells.

Cancer of Unknown Primary (CUP) represents 10% of those human tumors in which metastasis is detected, but the primary tumor cannot be located despite several exploratory tests. Since the tumor type is not known, the survival of these patients is very low; the implementation of the EPICUP® test will lead to the development of more specific treatments in the future, according to the results presented in Nature Reviews Clinical Oncology: "Prospective trials are now needed to determine how these CUP patients, now correctly diagnosed, can benefit from more specific and less aggressive treatments for their disease" Dr. Esteller concludes.

Source-Eurekalert

Key to Success in Immunotherapy is the Barrier Protein in Tumors
The mechanism underlying response or resistance to immunotherapy drugs can be revealed by the findings of researchers from the Johns Hopkins Bloomberg~Kimmel Institute

Blood Vessels can Actually Make Tumors
Production of new blood vessels normally occurs during development and to help repair injuries. Cancer hijacks this normal biological response to support its growth.